• Antineoplastic CAS 149647-78-9 Vorinostat Pharmaceutical Vorinostat Powder Vorinostat
  • Antineoplastic CAS 149647-78-9 Vorinostat Pharmaceutical Vorinostat Powder Vorinostat
  • Antineoplastic CAS 149647-78-9 Vorinostat Pharmaceutical Vorinostat Powder Vorinostat
  • Antineoplastic CAS 149647-78-9 Vorinostat Pharmaceutical Vorinostat Powder Vorinostat
  • Antineoplastic CAS 149647-78-9 Vorinostat Pharmaceutical Vorinostat Powder Vorinostat
  • Antineoplastic CAS 149647-78-9 Vorinostat Pharmaceutical Vorinostat Powder Vorinostat

Antineoplastic CAS 149647-78-9 Vorinostat Pharmaceutical Vorinostat Powder Vorinostat

Powder: Yes
Customized: Customized
Certification: GMP, HSE, ISO 9001, USP, BP
Suitable for: Elderly, Adult
State: Powder
Purity: >99%
Samples:
US$ 30/kg 1 kg(Min.Order)
| Request Sample
Customization:
Diamond Member Since 2021

Suppliers with verified business licenses

Manufacturer/Factory
  • Overview
  • Product Description
  • Product Details
  • Application&Function
  • Specification
Overview

Basic Info.

Model NO.
D-sung Vorinostat
Product Name
Vorinostat
Name
Vorinostat Powder
Appearance
White Powder
Color
White
Grade
Pharmaceutical Grade
Assay
HPLC 99%
Application
Pharmaceutical
Specific
COA
Test Method
HPLC
Shelf Life
2 Years
CAS No.
149647-78-9
Mf
C14h20n2o3
MW
264.32
Melting Point
161-162 C
Density
1.2
Transport Package
Negotiable
Specification
99%
Trademark
D-sung
Origin
Shaanxi Xi′an
Production Capacity
1000kg/Month

Product Description

Antineoplastic CAS 149647-78-9 Vorinostat Pharmaceutical Vorinostat Powder Vorinostat
Antineoplastic CAS 149647-78-9 Vorinostat Pharmaceutical Vorinostat Powder Vorinostat
Product Description
Antineoplastic CAS 149647-78-9 Vorinostat Pharmaceutical Vorinostat Powder VorinostatAntineoplastic CAS 149647-78-9 Vorinostat Pharmaceutical Vorinostat Powder Vorinostat
Product Details
Antineoplastic CAS 149647-78-9 Vorinostat Pharmaceutical Vorinostat Powder Vorinostat
Product name Vorinostat
Appearance White powder
CAS NO. 149647-78-9
MF C14H20N2O3
MW 264.3202
Vorinostat can play a role by inducing cell differentiation, blocking the cell cycle, and inducing cell regulation. Treatment of aggravation, persistence, and recurrence or ineffective cutaneous T-cell lymphoma (CTCL, a non-Hodgkin's lymphoma) after treatment with two systemic drugs. CTCL is a type of T cell carcinoma that affects the white blood cell types of the skin.
Application&Function
Antineoplastic CAS 149647-78-9 Vorinostat Pharmaceutical Vorinostat Powder Vorinostat

For the treatment of cutaneous manifestations in patients with cutaneous T-cell lymphoma who have progressive, persistent or recurrent disease on or following two systemic therapies; treatment of CTCL;treating acute myeloid leukemia.

Specification
Antineoplastic CAS 149647-78-9 Vorinostat Pharmaceutical Vorinostat Powder VorinostatAntineoplastic CAS 149647-78-9 Vorinostat Pharmaceutical Vorinostat Powder VorinostatAntineoplastic CAS 149647-78-9 Vorinostat Pharmaceutical Vorinostat Powder Vorinostat
Antineoplastic CAS 149647-78-9 Vorinostat Pharmaceutical Vorinostat Powder VorinostatAntineoplastic CAS 149647-78-9 Vorinostat Pharmaceutical Vorinostat Powder VorinostatAntineoplastic CAS 149647-78-9 Vorinostat Pharmaceutical Vorinostat Powder Vorinostat
Antineoplastic CAS 149647-78-9 Vorinostat Pharmaceutical Vorinostat Powder Vorinostat
 
 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Diamond Member Since 2021

Suppliers with verified business licenses

Manufacturer/Factory
Management System Certification
ISO 9001, ISO 14001, GMP, HACCP